All News Sichuan Kelun Pharmaceutical Co., Ltd.

Equities

002422

CNE100000PW7

End-of-day quote Shenzhen S.E. Other stock markets 18:00:00 2024-05-14 EDT			5-day change	1st Jan Change
34.04 ^CNY	-2.77%		+0.29%	+17.18%

04-25	Sichuan Kelun Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-10	Sichuan Kelun Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sichuan Kelun Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for the Year 2023	04-24	CI
Sichuan Kelun Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-24	CI
Sichuan Kelun Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	04-10	CI
US FDA to Accelerate Review of Kelun Pharma Unit's Lung Cancer Drug	03-12	MT
Kelun-Biotech Controlling Shareholder Ups Stake; Shares Rise 4%	01-22	MT
Kelun Pharmaceutical's Olaparib Tablets Get Nod from Chinese Drug Regulator	01-22	MT
Kelun Pharma Gets Registration Approval in China for Immune Thrombocytopenia Drug	01-17	MT
Kelun Pharma Sees Up to 50% Jump in 2023 Profit	01-15	MT
Kelun Pharma's Unit Gets US FDA's Orphan Drug Designation to A400	11-28	MT
Kelun Pharmaceutical's Unit Gains Registration Certificate for Ceftazidime Avibactam Sodium/Sodium Chloride Injection	11-01	MT
Sichuan Kelun Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-29	CI
Kelun Pharma Ends Cancer Drug Contract, Revises Partnership With Merck	23-10-23	MT
Global markets live: Foxconn, Roche, Eli Lilly, Chevron, Apple...	23-10-23
The good, the bad and the ugly	23-10-23
Merck discontinues some cancer drug development with China's Sichuan Kelun	23-10-23	RE
Kelun Pharma Unit Obtains Registration Approval in China for Bacterial Infection Drug	23-10-18	MT
Sichuan Kelun Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-29	CI
Sichuan Kelun Pharma to Start License Application Process For New Cancer Drug	23-08-15	MT
Kelun Pharma's Unit Gets Gadobutrol injection Certified	23-07-13	MT
Kelun Pharma Expects Up to 66% Jump in H1 Profit	23-07-05	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Sichuan Kelun Pharmaceutical Co., Ltd.

Equities

002422

CNE100000PW7

All News

Filters